Denis Chem Lab Ltd
₹0.00▲ +0.00 (+0.00%)
DENISCHEMLABLTD·NSE·Healthcare
Market Cap
99.82 Cr
PE Ratio
12.50
Volume
—
Day High - Low
—
52W High-Low
100.50 - 56.10
₹0.00▲ +0.00 (+0.00%)
Market Cap99.82 Cr
PE Ratio12.50
Volume—
Day High - Low—
52W High-Low100.50 - 56.10
Denis Chem Lab Ltd (DENISCHEMLABLTD): company summary
Denis Chem Lab Ltd (DENISCHEMLABLTD) is a micro-cap Healthcare company valued at ₹100 crore operating in Pharmaceuticals on the NSE and BSE.
Denis Chem Lab Ltd (DENISCHEMLABLTD) is a micro-cap Healthcare company valued at ₹100 crore operating in Pharmaceuticals on the NSE and BSE.
- Financial performance
- Revenue has been growing steadily at 4.5% a year over three years; profit grew 1.6% a year, behind revenue — margins are under pressure. Return on equity is 9.5%.
- Valuation multiples
- The stock trades at 12.5 times earnings, a discount to the Healthcare median of 32.0, 1.09 times book value. It yields 3.5%.
Generated from DocStoX data. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Not currently trading — we have seen no trades on NSE or BSE recently. It may be suspended, delisted, or renamed after a corporate action. Not a live price.
DocStoX Score
6.9/10
Fair
Fair Value
Sign in to see
ROE
9.52%
Average
P/E
12.50x
Cheap
Debt / Equity
0.04
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Fair
Price performance
52W₹56.10
₹100.50
DocStoX take
Supported by growth (8.2) and valuation (7.7), but weakest on quality (5.3). Scored on 4 of 5 measures.
DocStoX score
Medium confidence6.9
/10
Fair
Quality
Solid
ROE 9.5%
Valuation
Cheap
P/E 12.5×
Growth
Strong
Revenue +11.0% 5Y CAGR
Risk
Moderate
D/E 0.04
Momentum
No data
No technical indicators
Scored on 4 of 5 measures — the rest have no data for this company.
At a glance
Market Cap
₹100 Cr
52W High / Low
₹101 / ₹56
Dividend Yield
3.48%
Promoter Holding
38.98%
EPS (TTM)
₹5.82
Book Value
₹65.99
Key highlights
- Profit compounding 33% a year
- Low leverage — D/E 0.04
- Profitable in all of the last 5 years
- Small ₹100 cr company — thinner liquidity
4 Positives1 Watchout
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Pharmaceuticals
Explore Denis Chem Lab Ltd’s valuation
Free deep-dive tools · no sign-up
Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.
Denis Chem Lab Ltd peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
Sun Pharmaceutical Industries LimitedDivi's Laboratories LimitedTorrent Pharmaceuticals LimitedApollo Hospitals Enterprise LimitedZydus Lifesciences LimitedLaurus Labs LimitedCipla LimitedDr. Reddy's Laboratories LimitedAurobindo Pharma LimitedMankind Pharma LimitedLupin LimitedManipal Health Enterprises Limited
Compare Denis Chem Lab Ltd with peers
Denis Chem Lab Ltd vs Sun Pharmaceutical Industries LimitedDenis Chem Lab Ltd vs Divi's Laboratories LimitedDenis Chem Lab Ltd vs Torrent Pharmaceuticals LimitedDenis Chem Lab Ltd vs Apollo Hospitals Enterprise LimitedDenis Chem Lab Ltd vs Zydus Lifesciences LimitedDenis Chem Lab Ltd vs Laurus Labs Limited
Related tools & concepts
Value Denis Chem Lab Ltd with the ratios and calculators DocStoX uses in its analysis.
P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing